肿瘤学和血液学临床试验研发

在精准医学领域中,靶向肿瘤和血液疗法的临床试验已经变得异常复杂。 Whether you need support with early phase adaptive trial design, site selection, patient identification or targeted services for late-phase oncology trials, partner with a CRO, focused on oncology, who can enable you to improve the health and lives of those who desperately need it. 

档案

早期肿瘤学试验

篮式、平台式或伞式适应性试验

无论您是考虑进行篮式、平台式或伞式肿瘤学试验来检查实体瘤或血液系统恶性肿瘤,都应摆脱传统的肿瘤学试验设计,以纳入更具创造性和适应性的试验。 

早期精准医药和免疫治疗

Working with gene and cell therapies, such as cell-based immunotherapies and CAR T-cell requires a multi-pronged approach that goes beyond traditional clinical trials. From discovery to market, you can apply biomarker identification strategies, companion diagnostics, multi-level stratification designs and composite endpoints. 

晚期肿瘤学试验

针对性患者招募与研究中心数据

Leverage our experience with more than 140 immuno-oncology studies, including innovative CAR T studies. 然后,使用我们专有的数据工具选择高性能肿瘤学研究中心、吸引投资者、评估方案设计并确定潜在肿瘤学和免疫肿瘤学参与者的地理分布。

数据驱动型试验监督与管理

More than 90% of our Phase II & III oncology trials are delivered on-time in study startup. You’ll get access to novel technologies like Xcellerate Monitoring that helps proactively safeguard patient safety and improve data quality as well as Xcellerate Insights that gives you a secure, shared view of your oncology trial’s latest operational metrics. 项目经理和法规负责人团队可帮助您实现里程碑。 Finally, leverage our established relationships with oncology investigators, local and international key opinion leaders (KOLs), global collaborative groups and patient networks to help your cancer trial run efficiently. 

肿瘤学科研网络

Rely on the Covance Scientific Network to optimize your cancer trial. 该网络兼具专业知识、速度和质量优势,可帮助您缩短启动和招募时间。平均而言,我们的客户可以…… 

  • 将启动时间缩短25-30%
  • 加快首位患者入组以及总的试验入组时间
优化肿瘤学临床试验的招募